Creating and virtually screening databases of fluorescently-labelled compounds for the discovery of target-specific molecular probes

AbstractOur group has recently demonstrated that virtual screening is a useful technique for the identification of target-specific molecular probes. In this paper, we discuss some of our proof-of-concept results involving two biologically relevant target proteins, and report the development of a computational script to generate large databases of fluorescence-labelled compounds for computer-assisted molecular design. The virtual screening of a small library of 1,153 fluorescently-labelled compounds against two targets, and the experimental testing of selected hits reveal that this approach is efficient at identifying molecular probes, and that the screening of a labelled library is preferred over the screening of base compounds followed by conjugation of confirmed hits. The automated script for library generation explores the known reactivity of commercially available dyes, such as NHS-esters, to create large virtual databases of fluorescence-tagged small molecules that can be easily synthesized in a laboratory. A database of 14,862 compounds, each tagged with the ATTO680 fluorophore was generated with the automated script reported here. This library is available for downloading and it is suitable for virtual ligand screening aiming at the identification of target-specific fluorescent molecular probes.

[1]  K. Bhatia,et al.  Uses of botulinum toxin injection in medicine today , 2000, BMJ : British Medical Journal.

[2]  Pieter F. W. Stouten,et al.  Fast prediction and visualization of protein binding pockets with PASS , 2000, J. Comput. Aided Mol. Des..

[3]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[4]  C. E. Peishoff,et al.  A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.

[5]  M. Mezei,et al.  Molecular docking: a powerful approach for structure-based drug discovery. , 2011, Current computer-aided drug design.

[6]  Woo Kyung Moon,et al.  A Receptor‐Targeted Near‐Infrared Fluorescence Probe for In Vivo Tumor Imaging , 2002, Chembiochem : a European journal of chemical biology.

[7]  I. Johnson,et al.  The molecular probes handbook : a guide to fluorescent probes and labeling technologies , 2010 .

[8]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[9]  Andrew J. S. Knox,et al.  Unbiasing Scoring Functions: A New Normalization and Rescoring Strategy. , 2007 .

[10]  Torsten Witte,et al.  Autoantibody Detection Using Indirect Immunofluorescence on HEp‐2 Cells , 2009, Annals of the New York Academy of Sciences.

[11]  Etienne Weiss,et al.  Therapeutic antibodies: successes, limitations and hopes for the future , 2009, British journal of pharmacology.

[12]  M. Jolley Fluorescence Polarization Assays for the Detection of Proteases and Their Inhibitors , 1996 .

[13]  Wely B. Floriano,et al.  Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A. , 2013, Journal of medicinal chemistry.

[14]  Nagarajan Vaidehi,et al.  HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases. , 2004, Journal of medicinal chemistry.

[15]  Enno Schmidt,et al.  Modern diagnosis of autoimmune blistering skin diseases. , 2010, Autoimmunity reviews.

[16]  Alexander M. Lewis,et al.  Identification of a chemical probe for NAADP by virtual screening , 2009, Nature chemical biology.

[17]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[18]  Yanli Wang,et al.  PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .

[19]  Mitchell A. Avery,et al.  Identification of Novel Malarial Cysteine Protease Inhibitors Using Structure-Based Virtual Screening of a Focused Cysteine Protease Inhibitor Library , 2011, J. Chem. Inf. Model..

[20]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[21]  Markus Sauer,et al.  Spectroscopic study and evaluation of red-absorbing fluorescent dyes. , 2003, Bioconjugate chemistry.

[22]  Yvonne A. Evrard,et al.  Preclinical elopment of a Validated Immunofluorescence Assay γ H 2 AX as a Pharmacodynamic Marker of R oisomerase I Inhibitor Activity , 2010 .

[23]  R. Stevens,et al.  Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor. , 2011, Journal of medicinal chemistry.

[24]  W. Checovich,et al.  Fluorescence polarization — a new tool for cell and molecular biology , 1995, Nature.

[25]  R. Tsien,et al.  The Fluorescent Toolbox for Assessing Protein Location and Function , 2006, Science.

[26]  C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[27]  C. J. Lewis,et al.  Cyanine Dye Labeling Reagents: Sulfoindocyanine Succinimidyl Esters. , 1993 .

[28]  B. Shoichet,et al.  Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. , 2002, Journal of medicinal chemistry.

[29]  U. Panzer,et al.  An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  Jerome Hauer,et al.  Botulinum toxin as a biological weapon , 2001 .

[31]  S. R. Parker,et al.  Cyanine dye labeling reagents--carboxymethylindocyanine succinimidyl esters. , 1990, Cytometry.

[32]  Thomas A. Halgren Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..

[33]  R. Weissleder,et al.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.

[34]  J. Sobel,et al.  Foodborne Botulism in the United States, 1990–2000 , 2004, Emerging infectious diseases.

[35]  Peter Kolb,et al.  Structure-based discovery of β2-adrenergic receptor ligands , 2009, Proceedings of the National Academy of Sciences.

[36]  U. Sack,et al.  [Autoantibody detection by indirect immunofluorescence on HEp-2 cells]. , 2009, Deutsche medizinische Wochenschrift.

[37]  M. Allen,et al.  High Throughput Fluorescence Polarization: A Homogeneous Alternative to Radioligand Binding for Cell Surface Receptors , 2000, Journal of biomolecular screening.

[38]  Anders Karlén,et al.  Ligand Bias of Scoring Functions in Structure-Based Virtual Screening , 2006, J. Chem. Inf. Model..

[39]  John B. O. Mitchell,et al.  Scoring functions and enrichment: a case study on Hsp90 , 2007, BMC Bioinform..

[40]  W. Floriano,et al.  Systematic discovery of molecular probes targeting multiple non-orthosteric and spatially distinct sites in the botulinum neurotoxin subtype A (BoNT/A). , 2015, Molecular and cellular probes.

[41]  Brian K. Shoichet,et al.  Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1 B , 2022 .

[42]  S. Achilefu,et al.  Design, synthesis and evaluation of near-infrared fluorescent pH indicators in a physiologically relevant range. , 2005, Chemical communications.

[43]  Philip K. Russell,et al.  Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.

[44]  Shuowei Cai,et al.  Botulism Diagnostics: From Clinical Symptoms to in vitro Assays , 2007, Critical reviews in microbiology.

[45]  Ralph Weissleder,et al.  Near-infrared fluorescence: application to in vivo molecular imaging. , 2010, Current opinion in chemical biology.

[46]  Ralph Weissleder,et al.  A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. , 2004, Neoplasia.

[47]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[48]  M. Scheffner,et al.  A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.

[49]  Alexander D. MacKerell,et al.  Consideration of Molecular Weight during Compound Selection in Virtual Target-Based Database Screening , 2003, J. Chem. Inf. Comput. Sci..

[50]  E. Lazarides,et al.  Actin antibody: the specific visualization of actin filaments in non-muscle cells. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Riggs,et al.  Isothiocyanate compounds as fluorescent labeling agents for immune serum. , 1958, The American journal of pathology.

[52]  J. Jankovic,et al.  Botulinum toxin in clinical practice , 2004, Journal of Neurology, Neurosurgery & Psychiatry.